Black Diamond Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, everyone. My name is Mark Velleca, Chair of the Board of Directors of Black Diamond Therapeutics. The meeting is now called to order. I've asked Marishka DeToy of Marishka Goodwin Procter, our outside legal counsel, to record the minutes.
It is a pleasure to welcome our stockholders and visitors to the 2023 Annual Meeting of Stockholders of Black Diamond. This meeting is being held in accordance with the company's bylaws and Delaware law. We are conducting the annual meeting virtually and have stockholders attending via the web portal we provided.
Our meeting today will consist of the formal business at hand, which is described in our proxy statement and notice of Internet availability of proxy materials, copies of which were mailed on or about April 4, 2023, to all of our stockholders of record as of the close of business on March 20, 2023.
During this portion of the meeting, all discussion will be limited to the official business at hand. Second, we will answer any questions that have to do
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |